Brought to you by 
CNS drug developer Axsome nets $47.4mm in IPO
20 Nov 2015
Executive Summary
Axsome Therapeutics Inc. (CNS drug candidates) netted $47.4mm in its initial public offering of 5.7mm shares at $9. The company planned to sell 4.25mm shares at $11-13.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement